Ahmad A. Tarhini, John M. Kirkwood, Hussein Tawbi, William E. Gooding, Mohammed F. Islam and Sanjiv S. Agarwala Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma Cancer 112
Version of Record online: 18 JAN 2008 | DOI: 10.1002/cncr.23284
A second-line, phase 2, single-arm study of arsenic trioxide was conducted in patients with inoperable American Joint Committee on Cancer stage IV melanoma. As tested in this trial, arsenic trioxide was well tolerated and found to have limited activity in patients with metastatic melanoma.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field